sábado, 13 de diciembre de 2025
FDA Approves Gene Therapy (Waskyra) for Patients with Wiskott-Aldrich Syndrome +... ++
FDA Approves Gene Therapy (Waskyra) for Patients with Wiskott-Aldrich Syndrome
The U.S. Food and Drug Administration (FDA) has…
https://checkrare.com/
FDA NEWS
2025 Orphan Drugs: PDUFA Dates and FDA Approvals
https://checkrare.com/2025-orphan-drugs-pdufa-dates-and-fda-approvals/
Rare diseases and orphan drugs are at the forefront of novel development and groundbreaking research. Almost half of all novel medications approved by the U.S. Food and Drug Administration (FDA) are orphan drugs.
FDA Approves Obinutuzumab for Patients With Lupus Nephritis
https://checkrare.com/fda-approves-obinutuzumab-for-patients-with-lupus-nephritis/
The U.S. Food and Drug Administration (FDA) has approved Gazyva/Gazyvaro (obinutuzumab) for the treatment of adults with active lupus nephritis who are receiving standard of care.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario